
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Second Department of Surgery, Nagoya University School of Medicine, Nagoya 466-8550, Japan
Purpose: Somatic mutations in mitochondrial DNA (mtDNA) have recently been detected in various cancers. These mutations could possibly be detected in serum because mtDNA has a higher copy number than nuclear DNA. Thus, we examined genetic alterations in the D-loop region of mtDNA in hepatocellular carcinoma (HCC) patients.
Experimental Design: Fifty patients with HCC were investigated in this study. Somatic mutations in the D-loop region of tumor mtDNA were screened by direct sequencing, and then the paired serum samples were investigated using mutation-specific mismatch ligation assay.
Results: Fifteen of 100 sequence variants that were detected in tumor mtDNA have not been recorded previously. True somatic mutations in the D-loop region were detected in 17 of 50 patients (34%). Subsequent screening for paired serum by mismatch ligation assay revealed that 5 of 15 paired serum samples (33%) contained the same mutations as primary tumors.
Conclusions: mtDNA mutation may be a novel tumor marker of HCC and may prove effective for detection of tumor DNA in the serum.
This article has been cited by other articles:
![]() |
S. Zhou, K. Kassauei, D. J. Cutler, G. C. Kennedy, D. Sidransky, A. Maitra, and J. Califano An Oligonucleotide Microarray for High-Throughput Sequencing of the Mitochondrial Genome J. Mol. Diagn., September 1, 2006; 8(4): 476 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, W. Qin, P. Bradley, A. Wessel, C. L. Puckett, and E. R. Sauter Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid Carcinogenesis, January 1, 2005; 26(1): 145 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maitra, Y. Cohen, S. E.D. Gillespie, E. Mambo, N. Fukushima, M. O. Hoque, N. Shah, M. Goggins, J. Califano, D. Sidransky, et al. The Human MitoChip: A High-Throughput Sequencing Microarray for Mitochondrial Mutation Detection Genome Res., May 1, 2004; 14(5): 812 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
L-J C Wong, D-J Tan, R-K Bai, K-T Yeh, and J Chang Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile? J. Med. Genet., May 1, 2004; 41(5): e65 - e65. [Full Text] [PDF] |
||||
![]() |
T. El-Hefnawy, S. Raja, L. Kelly, W. L. Bigbee, J. M. Kirkwood, J. D. Luketich, and T. E. Godfrey Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics Clin. Chem., March 1, 2004; 50(3): 564 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W.K. Chiu, L. Y.S. Chan, N. Y.L. Lam, N. B.Y. Tsui, E. K.O. Ng, T. H. Rainer, and Y.M. D. Lo Quantitative Analysis of Circulating Mitochondrial DNA in Plasma Clin. Chem., May 1, 2003; 49(5): 719 - 726. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |